David Smoller
SlowingNamed in filings at Cultivation Capital Life Sciences
- Board seats filed
- 8
Named in filings at Cultivation Capital Life Sciences
all filings on record
last 24 months
from a verified or cited source
| ProteoWise | Biotech & pharma | December 2024 | None on file |
| Maximum Fidelity Surgical Simulations | Healthcare services | June 2024 | None on file |
| Panome Bio | Biotech & pharma | February 2023 | None on file |
| Canopy Biosciences | Biotech & pharma | October 2016 | None on file |
| Apse | AI & machine learning | September 2014 | None on file |
| ImmunoPhotonics | Biotech & pharma | June 2014 | None on file |
| Adarza BioSystems | Biotech & pharma | June 2014 | Rivervest |
| Kypha | Medical devices | December 2013 | None on file |
The company and date are what the SEC filing shows, not a statement of investment thesis. A partner can sit on a board for reasons that say nothing about what their firm funds today. The sector is not a filing value: it is Lev’s own classification of each company, shown only when we found a specific, checkable source for it; otherwise it reads “Not yet classified.” “Also on the board from” names another tracked firm with a partner on the same board, both with a clean identity match. It is not a claim either firm led or co-led the round, and “None on file” means no other tracked firm’s partner shares this specific board seat, not that no one else invested. Sorted newest first by default; click a column to change it. Something wrong? Tell us.
Classified sectors of companies where filings name David Smoller on the board, based on 8 filed seats with a verified or cited source.